Related references
Note: Only part of the references are listed.Modulating proteasome inhibitor tolerance in multiple myeloma: an alternative strategy to reverse inevitable resistance
Maolin Ge et al.
BRITISH JOURNAL OF CANCER (2021)
Metabolic compensation activates pro-survival mTORC1 signaling upon 3-phosphoglycerate dehydrogenase inhibition in osteosarcoma
Richa Rathore et al.
CELL REPORTS (2021)
Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma
Marcus A. Weinman et al.
CANCER CELL INTERNATIONAL (2021)
Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs
Amy K. LeBlanc et al.
CLINICAL CANCER RESEARCH (2021)
Recent Advances in the Discovery of Biomarkers for Canine Osteosarcoma
Anita K. Luu et al.
FRONTIERS IN VETERINARY SCIENCE (2021)
Assessing a Novel 3D Assay System for Drug Screening against OS Metastasis
Natalie Koons et al.
PHARMACEUTICALS (2021)
Sustained and controlled delivery of doxorubicin from an in-situ setting biphasic hydroxyapatite carrier for local treatment of a highly proliferative human osteosarcoma
Yang Liu et al.
ACTA BIOMATERIALIA (2021)
The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation
Chao Jing et al.
THERANOSTICS (2021)
ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-kappa B Pathway
Qingshan Huang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
The Proteasome Inhibitor Ixazomib Inhibits the Formation and Growth of Pulmonary and Abdominal Osteosarcoma Metastases in Mice
Michael A. Harris et al.
CANCERS (2020)
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers
Ayuko Hoshino et al.
CELL (2020)
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
Jeremy J. McGuire et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Osteosarcoma-Derived Extracellular Vesicles Induce Lung Fibroblast Reprogramming
Alekhya Mazumdar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
A Comparative Oncology Drug Discovery Pipeline to Identify and Validate New Treatments for Osteosarcoma
Jason A. Somarelli et al.
CANCERS (2020)
Improving human cancer therapy through the evaluation of pet dogs
Amy K. LeBlanc et al.
NATURE REVIEWS CANCER (2020)
Exosomal communication by metastatic osteosarcoma cells modulates alveolar macrophages to an M2 tumor-promoting phenotype and inhibits tumoricidal functions
Kerri Wolf-Dennen et al.
ONCOIMMUNOLOGY (2020)
Protein profiling of osteosarcoma tissue and soft callus unveils activation of the unfolded protein response pathway
Parunya Chaiyawat et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2019)
Mass spectrometry-based proteome profiling of extracellular vesicles and their roles in cancer biology
Raju Bandu et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2019)
Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping
Stamatia Rontogianni et al.
COMMUNICATIONS BIOLOGY (2019)
Next-generation proteasome inhibitors for cancer therapy
Ji Eun Park et al.
TRANSLATIONAL RESEARCH (2018)
Pre-clinical evaluation of proteasome inhibitors for canine and human osteosarcoma
K. Patatsos et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2018)
A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease
Jacqueline Brady et al.
TRANSLATIONAL ONCOLOGY (2018)
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Wu Zhang et al.
CELL REPORTS (2018)
Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives
Jessica Marinello et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
The autophagy inhibitor spautin-1, either alone or combined with doxorubicin, decreases cell survival and colony formation in canine appendicular osteosarcoma cells
Courtney R. Schott et al.
PLOS ONE (2018)
Efficient ultrafiltration-based protocol to deplete extracellular vesicles from fetal bovine serum
Roman Kornilov et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Bortezomib sensitizes human osteosarcoma cells to adriamycin-induced apoptosis through ROS-dependent activation of p-eIF2α/ATF4/CHOP axis
Miao Xian et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Capzimin is a potent and specific inhibitor of proteasome isopeptidase Rpn11
Jing Li et al.
NATURE CHEMICAL BIOLOGY (2017)
Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance
Y. Song et al.
ONCOGENE (2017)
Proteasome inhibitors: structure and function
Ana T. Nunes et al.
SEMINARS IN ONCOLOGY (2017)
Down-regulation of RPS9 Inhibits Osteosarcoma Cell Growth through Inactivation of MAPK Signaling Pathway
Dong-dong Cheng et al.
JOURNAL OF CANCER (2017)
Comparative review of human and canine osteosarcoma: morphology, epidemiology, prognosis, treatment and genetics
Siobhan Simpson et al.
ACTA VETERINARIA SCANDINAVICA (2017)
Pharmacokinetics of ixazomib, an oral proteasome inhibitor, in solid tumour patients with moderate or severe hepatic impairment
Neeraj Gupta et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo
James J. Morrow et al.
CLINICAL CANCER RESEARCH (2016)
Multimodal transfer of MDR by exosomes in human osteosarcoma
Elena Torreggiani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Canine Osteosarcoma Treated by Post-Amputation Sequential Accelerated Doxorubicin and Carboplatin Chemotherapy: 38 Cases
Angela E. Frimberger et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2016)
Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
Joanna Kowal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Proteomic profiling of NCI-60 extracellular vesicles uncovers common protein cargo and cancer type-specific biomarkers
Stephanie N. Hurwitz et al.
ONCOTARGET (2016)
Extracellular vesicles secreted by highly metastatic clonal variants of osteosarcoma preferentially localize to the lungs and induce metastatic behaviour in poorly metastatic clones
Rebecca Macklin et al.
ONCOTARGET (2016)
Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study
Mikolaj P. Zaborowski et al.
BIOSCIENCE (2015)
Ribosomal protein S3 regulates GLI2-mediated osteosarcoma invasion
Hiroko Nagao-Kitamoto et al.
CANCER LETTERS (2015)
Anthracyclines induce double-strand DNA breaks at active gene promoters
Fan Yang et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2015)
A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis
Branden S. Moriarity et al.
NATURE GENETICS (2015)
Targeting the translation machinery in cancer
Mamatha Bhat et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes
Shivakumar Keerthikumar et al.
ONCOTARGET (2015)
Identification of Synergistic, Clinically Achievable, Combination Therapies for Osteosarcoma
Diana Yu et al.
SCIENTIFIC REPORTS (2015)
Extracellular vesicles as emerging intercellular communicasomes
Yae Jin Yoon et al.
BMB REPORTS (2014)
Proteotoxic crisis, the ubiquitin-proteasome system, and cancer therapy
Raymond J. Deshaies
BMC BIOLOGY (2014)
Proteasome assembly
Zhu Chao Gu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Efficacy of therapy with bortezomib in solid tumors: a review based on 32 clinical trials
Zebo Huang et al.
FUTURE ONCOLOGY (2014)
Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology
Joelle M. Fenger et al.
ILAR JOURNAL (2014)
Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma
Lenka Kubiczkova et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Inhibiting valosin-containing protein suppresses osteosarcoma cell metastasis via AKT/nuclear factor of kappa B signaling pathway in vitro
Xin Hua Long et al.
INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY (2013)
Bortezomib induces apoptosis and autophagy in osteosarcoma cells through mitogen-activated protein kinase pathway in vitro
Zhiyuan Lou et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2013)
Toxicity and efficacy of a novel doxorubicin and carboplatin chemotherapy protocol for the treatment of canine appendicular osteosarcoma following limb amputation
A. E. Lane et al.
AUSTRALIAN VETERINARY JOURNAL (2012)
The proteasomal de-ubiquitinating enzyme POH1 promotes the double-strand DNA break response
Laura R. Butler et al.
EMBO JOURNAL (2012)
Comparison of three-view thoracic radiography and computed tomography for detection of pulmonary nodules in dogs with neoplasia
Laura J. Armbrust et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2012)
A Review of the Association between Osteosarcoma Metastasis and Protein Translation
T. S. Osborne et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2012)
Therapeutic targeting of cancer cell cycle using proteasome inhibitors
Namrata Rastogi et al.
CELL DIVISION (2012)
Proteasome inhibition with bortezomib suppresses growth and induces apoptosis in osteosarcoma
Yuriy Shapovalov et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Exosomes: Extracellular organelles important in intercellular communication
Suresh Mathivanan et al.
JOURNAL OF PROTEOMICS (2010)
Expression of b-FGF and endostatin and their clinical significance in human osteosarcoma
Chao-jian Xu et al.
Orthopaedic Surgery (2010)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Use of Single-Agent Carboplatin as Adjuvant or Neoadjuvant Therapy in Conjunction With Amputation for Appendicular Osteosarcoma in Dogs
Brenda Philips et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2009)
Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction
S. Baritaki et al.
ONCOGENE (2009)
The proteasome: Overview of structure and functions
Keiji Tanaka
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2009)
DNA topoisomerase II and its growing repertoire of biological functions
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Targeting DNA topoisomerase II in cancer chemotherapy
John L. Nitiss
NATURE REVIEWS CANCER (2009)
Targeting apoptosis in solid tumors:: the role of bortezomib from preclinical to clinical evidence
Antonio Russo et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Evaluation of survival time in dogs with stage III osteosarcoma that undergo treatment: 90 cases (1985-2004)
SE Boston et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2006)
Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma
R Chun et al.
JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION (2005)
The proteasome: A suitable antineoplastic target
J Adams
NATURE REVIEWS CANCER (2004)
Inhibition of proteasome activity induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes
S Meiners et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Role of Rpn11 metalloprotease in deubiquitination and degradation by the 26S proteasome
R Verma et al.
SCIENCE (2002)
Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation
R Bernardi et al.
ONCOGENE (2000)
Share Paper
